Do different formulations of botulinum toxin type A really have different migration characteristics?

Journal of Cosmetic Dermatology

Volumn 7, Issue 3, 2008, Pages 230-

  Karsai, Syrus ^a   Raulin, Christian ^a,b  

^a LASERKLINIK KARLSRUHE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

DOSE CALCULATION; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; ELECTROMYOGRAM; HUMAN; LETTER; PRIORITY JOURNAL; WRINKLE;

BOTULINUM TOXIN TYPE A; FOREHEAD; HUMANS; INJECTIONS, INTRADERMAL; NEUROMUSCULAR AGENTS;

EID: 48949099432     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2008.00395.x     Document Type: Letter

References (3)

1. Cliff SH, Judodihardjo H, Eltringham E. Different formulations of botulinum toxin type A have different migration characteristics: A double-blind, randomized study. J Cosmet Dermatol 2008; 7: 50-4.
2. De Almeida AT, De.Boulle K. Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications. J Cosmet Laser Ther 2007; 9 (Suppl. 1): 17-22.
3. Karsai S, Adrian R, Hammes S, Thimm J, Raulin C. A randomized double-blind study of the effect of botox and dysport/reloxin on forehead wrinkles and electromyographic activity. Arch Dermatol 2007; 143: 1447-9.